2024
Ackun-Farmmer MA., Shirkey, M. W., Oakes, R. S., Shah, S. A., Edwards, C., Kapnick, S., Carey, S. T., Yanes, A., Bromberg, J., & Jewell, C. M. (2024). Engineered immune constructs alter Antigen-Specific immune tolerance and confer durable protection in Myelin-Driven autoimmunity. ACS Nano, 18(46), 31780–31793.
Bridgeman CJ, Shen R, McIlvaine RA, Edwards C, Ackun-Farmmer MA, Jewell CM. Synthetic Organic Materials for Targeting Immunotherapies to Lymph Nodes. Chemistry of Materials. 2024.
Xiao, B., Ackun-Farmmer MA, Adjei-Sowah, E., Liu, Y., Chandrasiri, I., & Benoit, D. S. W. (2024). Advancing Bone-Targeted Drug Delivery: leveraging biological factors and nanoparticle designs to improve therapeutic efficacy. ACS Biomaterials Science & Engineering, 10(4), 2224–2234.
2023
Ackun-Farmmer MA, Jewell CM. Delivery route considerations for designing antigen-specific biomaterial strategies to combat autoimmunity. Adv Nanobiomed Res. 2023;3(3).
Ackun-Farmmer M, Jewell CM. Enhancing the functionality of self-assembled immune signals using chemical crosslinks. Front Immunol. 2023;14:1079910.
Gammon JM, Carey ST, Saxena V, Eppler HB, Tsai SJ, Paluskievicz C, Xiong Y, Li L, Ackun-Farmmer M, Tostanoski LH, Gosselin EA, Yanes AA, Zeng X, Oakes RS, Bromberg JS, Jewell CM. Engineering the lymph node environment promotes antigen-specific efficacy in type 1 diabetes and islet transplantation. Nat Commun. 2023;14(1):681.
2022
Ackun-Farmmer MA, Xiao B, Newman MR, Benoit DSW. Macrophage depletion increases target specificity of bone-targeted nanoparticles. J Biomed Mater Res A. 2022;110(1):229-238.
Ackun-Farmmer MA, Alwaseem H, Counts M, Bortz A, Giovani S, Frisch BJ, Fasan R, Benoit DSW. Nanoparticle-Mediated Delivery of Micheliolide Analogs to Eliminate Leukemic Stem Cells in the Bone Marrow. Adv Ther (Weinh). 2022;5(1).
2021
Ackun-Farmmer MA, Overby CT, Haws BE, Choe R, Benoit DSW. Biomaterials for Orthopaedic Diagnostics and Theranostics. Curr Opin Biomed Eng. 2021;19.
Ackun-Farmmer MA, Soto CA, Lesch ML, Byun D, Yang L, Calvi LM, Benoit DSW, Frisch BJ. Reduction of leukemic burden via bone-targeted nanoparticle delivery of an inhibitor of C-chemokine (C-C motif) ligand 3 (CCL3) signaling. FASEB J. 2021;35(4):e21402.
2020
Ackun-Farmmer MA, Alatise KL, Cross G, Benoit DSW. Ligand Density Controls C-Type Lectin-Like Molecule-1 Receptor-Specific Uptake of Polymer Nanoparticles. Adv Biosyst. 2020;4(11):e2000172.
Benoit, D. S., Overby, C. T., Sims Jr, K. R., & Ackun-Farmmer, M. A. (2020). Drug delivery systems. In Biomaterials science(pp. 1237-1266). Academic Press.
2017
Wang Y, Newman MR, Ackun-Farmmer M, Baranello MP, Sheu TJ, Puzas JE, Benoit DSW. Fracture-Targeted Delivery of beta-Catenin Agonists via Peptide-Functionalized Nanoparticles Augments Fracture Healing. ACS Nano. 2017;11(9):9445-9458.
2014
York JN, Albanese C, Rodriguez O, Le YC, Ackun-Farmmer M, Van Keuren E. The effects of particle shape and size on T2 relaxation in magnetic resonance imaging. J Biomed Nanotechnol. 2014;10(11):3392-3396.
